Dumb Luck Strikes Again!
Then, on Tuesday, July 2, 2002, at a meeting of the 20th World Congress of Dermatology in Paris, France, a series of studies detailing the superior wrinkle-reducing properties of a patented oligo-peptide “called Pal-KTTKS” versus retinol, vitamin C, and placebo, on “photo-aged skin” was presented.¹,² “As luck would have it,” Dr. Mowrey states, “the anti-wrinkle oligo-peptide tested in the breakthrough clinical trials turned out to be a key ingredient in the StriVectin® cream.”
In the trials, subjects applied the patented peptide solution to the crows' feet area on one side of the face, and a cream containing either retinol, vitamin C, or a placebo to the other side.
Subjects in the Pal-KTTKS/retinol study applied the cream once a day for 2 months and then twice a day for the next 2 months. Using special image analysis, the study's authors reported “significant improvement” in both the overall appearance of skin tone and wrinkles for those women using the peptide solution.
Better yet, at the 2-month halfway point, the peptide solution worked nearly 1.5 times faster than retinol “in measured parameters,” and without the inflammation retinol often causes in sensitive skin. As was expected, the results of the remaining studies confirmed that the Pal-KTTKS solution's effectiveness at reducing the appearance of fine lines and wrinkles far exceeded both vitamin C and placebo. A smoother, younger complexion, with less irritation and faster results—all without expensive (and painful) peels, implants or injections.
To Order By Phone Call 1-800-919-9715
